A National Institutes of Health research group with extensive experience studying ebolavirus countermeasures has successfully developed a vaccine against Sudan virus (SUDV) based on the licensed Ebola virus (EBOV) vaccine.
Golden Helix — Enabling Precision Medicine
For over 20 years Golden Helix has been a software company that innovates genetic analysis software for next-generation sequencing (NGS) – and, believing that its customers and employees are at the heart of its success, it has built a glowing reputation as the industry leader in its field.
Inimmune outlines vaccine adjuvant work
Inimmune is a leader in the discovery and development of vaccine adjuvants with over 20 years of expertise in their safe and effective use.
Momentum continues in UM’s first year as “R1” research university
The University of Montana was named a top-tier “R1” research institution last year. It was the culmination of a decades-long goal for UM, and the science surge has only gained momentum in the first six months of the 2022-23 fiscal year.
Bitterroot College, Bitterroot Health partner on health care workforce
Health care is Montana’s largest industry and is projected to experience more job growth than any other industry in the state over the next eight years. However, with the State employment rate hovering around 2.6%, health care facilities are facing extreme workforce shortages. Because of this high demand for health care workers, Bitterroot Health and Bitterroot College are partnering to address these workforce issues through innovation and collaboration.
Montana State joins regional alliance for high-tech economic development
Montana State University has joined with a dozen other universities in the region to form a partnership aimed at creating economic development opportunities around emerging high-tech industries.
INDUSTRY Bozeman breaks ground at new MSU Innovation Campus facility
INDUSTRY Bozeman, a multi-tenant modern office space, has broken ground on an 87,000-square-foot building to be located on the Montana State University Innovation Campus.
Tonix Pharmaceuticals Announces Collaboration with Boston Children’s Hospital
Montana’s Tonix Pharmaceuticals, a clinical-stage biopharmaceutical company, announced that it has entered into a sponsored research agreement with Boston Children’s Hospital to study TNX-15001 (Fc-modified anti-CD40L mAb) for the prevention of graft-versus-host disease (GvHD) after hematopoietic stem cell transplantation (HCT) in animals.
$5M funding, new UM research office to boost Montana rural health
The University of Montana recently secured $5.1 million in federal grants from the Health Resource and Service Administration, leading to the formation of a new UM Office of Health Research & Partnership. The office will use the HRSA funding for programs to bolster the health care workforce and increase access to quality health care in rural and underserved parts of Montana.